Phenylketonuria (PKU) Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Region:Global

Author(s):

Product Code:99SGL280Mac20201100004442

Download Sample Report download
Buy the Full ReportStarting from $2800
Published on

November 2020

Total pages

95

Table of Content

Download Sample Report download
Buy the Full ReportStarting from $2800

About the Report

About the Report

Summary

Further key aspects of the report indicate that:

Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology

Chapter 2: Global Industry Summary

Chapter 3: Market Dynamics

Chapter 4: Global Market Segmentation by region, type and End-Use

Chapter 5: North America Market Segmentation by region, type and End-Use

Chapter 6: Europe Market Segmentation by region, type and End-Use

Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use

Chapter 8: South America Market Segmentation by region, type and End-Use

Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.

Chapter 10: Market Competition by Companies

Chapter 11: Market forecast and environment forecast.

Chapter 12: Industry Summary.

The global Phenylketonuria (PKU) market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.

Based on the type of product, the global Phenylketonuria (PKU) market segmented into

Medications

Supplements

Others

Based on the end-use, the global Phenylketonuria (PKU) market classified into

Household

Hospital

Others

Based on geography, the global Phenylketonuria (PKU) market segmented into

North America [U.S., Canada, Mexico]

Europe [Germany, UK, France, Italy, Rest of Europe]

Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]

South America [Brazil, Argentina, Rest of Latin America]

Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]

And the major players included in the report are

Biomarin

Vitaflo

Mead Johnson

Nutricia

Cambrooke

Dr. Schar

Prominmetabolics

PKU Perspectives

Products

Table of Contents

Table of Contents

Table of Contents

1 RESEARCH SCOPE

1.1 Research Product Definition

1.2 Research Segmentation

1.2.1 Product Type

1.2.2 Main product Type of Major Players

1.3 Demand Overview

1.4 Research Methodology

2 GLOBAL PHENYLKETONURIA (PKU) INDUSTRY

2.1 Summary about Phenylketonuria (PKU) Industry

2.2 Phenylketonuria (PKU) Market Trends

2.2.1 Phenylketonuria (PKU) Production & Consumption Trends

2.2.2 Phenylketonuria (PKU) Demand Structure Trends

2.3 Phenylketonuria (PKU) Cost & Price

3 MARKET DYNAMICS

3.1 Manufacturing & Purchasing Behavior in 2020

3.2 Market Development under the Impact of COVID-19

3.2.1 Drivers

3.2.2 Restraints

3.2.3 Opportunity

3.2.4 Risk

4 GLOBAL MARKET SEGMENTATION

4.1 Region Segmentation (2017 to 2021f)

4.1.1 North America (U.S., Canada and Mexico)

4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)

4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)

4.1.4 South America (Brazil,, Argentina, Rest of Latin America)

4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)

4.2 Product Type Segmentation (2017 to 2021f)

4.2.1 Medications

4.2.2 Supplements

4.2.3 Others

4.3 Consumption Segmentation (2017 to 2021f)

4.3.1 Household

4.3.2 Hospital

4.3.3 Others

5 NORTH AMERICA MARKET SEGMENT

5.1 Region Segmentation (2017 to 2021f)

5.1.1 U.S.

5.1.2 Canada

5.1.3 Mexico

5.2 Product Type Segmentation (2017 to 2021f)

5.2.1 Medications

5.2.2 Supplements

5.2.3 Others

5.3 Consumption Segmentation (2017 to 2021f)

5.3.1 Household

5.3.2 Hospital

5.3.3 Others

5.4 Impact of COVID-19 in North America

6 EUROPE MARKET SEGMENTATION

6.1 Region Segmentation (2017 to 2021f)

6.1.1 Germany

6.1.2 UK

6.1.3 France

6.1.4 Italy

6.1.5 Rest of Europe

6.2 Product Type Segmentation (2017 to 2021f)

6.2.1 Medications

6.2.2 Supplements

6.2.3 Others

6.3 Consumption Segmentation (2017 to 2021f)

6.3.1 Household

6.3.2 Hospital

6.3.3 Others

6.4 Impact of COVID-19 in Europe

7 ASIA-PACIFIC MARKET SEGMENTATION

7.1 Region Segmentation (2017 to 2021f)

7.1.1 China

7.1.2 India

7.1.3 Japan

7.1.4 South Korea

7.1.5 Southeast Asia

7.1.6 Australia

7.1.7 Rest of Asia Pacific

7.2 Product Type Segmentation (2017 to 2021f)

7.2.1 Medications

7.2.2 Supplements

7.2.3 Others

7.3 Consumption Segmentation (2017 to 2021f)

7.3.1 Household

7.3.2 Hospital

7.3.3 Others

7.4 Impact of COVID-19 in Europe

8 SOUTH AMERICA MARKET SEGMENTATION

8.1 Region Segmentation (2017 to 2021f)

8.1.1 Brazil

8.1.2 Argentina

8.1.3 Rest of Latin America

8.2 Product Type Segmentation (2017 to 2021f)

8.2.1 Medications

8.2.2 Supplements

8.2.3 Others

8.3 Consumption Segmentation (2017 to 2021f)

8.3.1 Household

8.3.2 Hospital

8.3.3 Others

8.4 Impact of COVID-19 in Europe

9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION

9.1 Region Segmentation (2017 to 2021f)

9.1.1 GCC

9.1.2 North Africa

9.1.3 South Africa

9.1.4 Rest of Middle East and Africa

9.2 Product Type Segmentation (2017 to 2021f)

9.2.1 Medications

9.2.2 Supplements

9.2.3 Others

9.3 Consumption Segmentation (2017 to 2021f)

9.3.1 Household

9.3.2 Hospital

9.3.3 Others

9.4 Impact of COVID-19 in Europe

10 COMPETITION OF MAJOR PLAYERS

10.1 Brief Introduction of Major Players

10.1.1 Biomarin

10.1.2 Vitaflo

10.1.3 Mead Johnson

10.1.4 Nutricia

10.1.5 Cambrooke

10.1.6 Dr. Schar

10.1.7 Prominmetabolics

10.1.8 PKU Perspectives

10.2 Phenylketonuria (PKU) Sales Date of Major Players (2017-2020e)

10.2.1 Biomarin

10.2.2 Vitaflo

10.2.3 Mead Johnson

10.2.4 Nutricia

10.2.5 Cambrooke

10.2.6 Dr. Schar

10.2.7 Prominmetabolics

10.2.8 PKU Perspectives

10.3 Market Distribution of Major Players

10.4 Global Competition Segmentation

11 MARKET FORECAST

11.1 Forecast by Region

11.2 Forecast by Demand

11.3 Environment Forecast

11.3.1 Impact of COVID-19

11.3.2 Geopolitics Overview

11.3.3 Economic Overview of Major Countries

12 REPORT SUMMARY STATEMENT


List of Figure

List of Figure

1.Figure Global Phenylketonuria (PKU) Market Size under the Impact of COVID-19, 2017-2021f (USD Million)

2.Figure Global Phenylketonuria (PKU) Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)

3.Figure Global Phenylketonuria (PKU) Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)

4.Figure Global Phenylketonuria (PKU) Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)

5.Figure Global Phenylketonuria (PKU) Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)

6.Figure Global Phenylketonuria (PKU) Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)

7.Figure Global Phenylketonuria (PKU) Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)

8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

13.Figure Medications Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

14.Figure Supplements Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

15.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

16.Figure Household Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

17.Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

18.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

19.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

20.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

21.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

22.Figure Medications Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

23.Figure Supplements Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

24.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

25.Figure Household Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

26.Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

27.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

28.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

29.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

30.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

31.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

32.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

33.Figure Medications Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

34.Figure Supplements Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

35.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

36.Figure Household Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

37.Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

38.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

39.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

40.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

41.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

42.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

43.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

44.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

45.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

46.Figure Medications Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

47.Figure Supplements Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

48.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

49.Figure Household Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

50.Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

51.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

52.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

53.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

54.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

55.Figure Medications Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

56.Figure Supplements Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

57.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

58.Figure Household Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

59.Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

60.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

61.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

62.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

63.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

64.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

65.Figure Medications Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

66.Figure Supplements Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

67.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

68.Figure Household Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

69.Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

70.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f

71.Figure Phenylketonuria (PKU) Sales Revenue (Million USD) of Biomarin 2017-2020e

72.Figure Phenylketonuria (PKU) Sales Revenue (Million USD) of Vitaflo 2017-2020e

73.Figure Phenylketonuria (PKU) Sales Revenue (Million USD) of Mead Johnson 2017-2020e

74.Figure Phenylketonuria (PKU) Sales Revenue (Million USD) of Nutricia 2017-2020e

75.Figure Phenylketonuria (PKU) Sales Revenue (Million USD) of Cambrooke 2017-2020e

76.Figure Phenylketonuria (PKU) Sales Revenue (Million USD) of Dr. Schar 2017-2020e

77.Figure Phenylketonuria (PKU) Sales Revenue (Million USD) of Prominmetabolics 2017-2020e

78.Figure Phenylketonuria (PKU) Sales


List of Table

List of Table

1.Table Phenylketonuria (PKU) Product Type Overview

2.Table Phenylketonuria (PKU) Product Type Market Share List

3.Table Phenylketonuria (PKU) Product Type of Major Players

4.Table Brief Introduction of Biomarin

5.Table Brief Introduction of Vitaflo

6.Table Brief Introduction of Mead Johnson

7.Table Brief Introduction of Nutricia

8.Table Brief Introduction of Cambrooke

9.Table Brief Introduction of Dr. Schar

10.Table Brief Introduction of Prominmetabolics

11.Table Brief Introduction of PKU Perspectives

12.Table Products & Services of Biomarin

13.Table Products & Services of Vitaflo

14.Table Products & Services of Mead Johnson

15.Table Products & Services of Nutricia

16.Table Products & Services of Cambrooke

17.Table Products & Services of Dr. Schar

18.Table Products & Services of Prominmetabolics

19.Table Products & Services of PKU Perspectives

20.Table Market Distribution of Major Players

21.Table Global Major Players Sales Revenue (Million USD) 2017-2020e

22.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e

23.Table Global Phenylketonuria (PKU) Market Forecast (Million USD) by Region 2021f-2026f

24.Table Global Phenylketonuria (PKU) Market Forecast (Million USD) Share by Region 2021f-2026f

25.Table Global Phenylketonuria (PKU) Market Forecast (Million USD) by Demand 2021f-2026f

26.Table Global Phenylketonuria (PKU) Market Forecast (Million USD) Share by Demand 2021f-2026f

You can also purchase parts of this report.
Do you want to check out a section wise price list?
Get Price Break-up

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022